The rapid pathogen detection in USA market is expected to increase by USD 178 百万, 以复合年增长率 (复合年增长率) 的 6.8% 从 2022 到 2028, according to the latest edition of the Rapid Pathogen Detection Market in USA Report.

该行业报告提供了美国市场的市场预测, 接下来是对产品的详细分析, and testing method. The USA market data on rapid pathogen detection can be segmented by product: detection devices, 传感器. 据研究, the detection devices segment had the largest share in the rapid pathogen detection market in USA. Rapid pathogen detection market is further segmented by testing method: immunological analysis, 质谱, polymerase chain reaction (聚合酶链式反应). 在 2021, the immunological analysis segment made up the largest share of revenue generated by the rapid pathogen detection market.

The detection device market is further segmented into handheld, installed, 便携的, tabletop. Gen Consulting Company research indicates that the handheld segment occupied the largest share of this market in 2021 预计未来几年需求将达到最高.

The USA rapid pathogen detection market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players ANP Technologies Inc., Battelle, Bavarian Nordic A/S, bioMérieux Inc., Bruker Detection Corp, Corgenix Medical Corp., Electronic Sensor Technology Inc., Emergent BioSolutions Inc., Eurofins Scientific, 葛兰素史克公司 (GSK), InBios International Inc., Inovio Pharmaceuticals Inc., LGC Biosearch Technologies, 默克公司, Novavax Inc., Soligenix Inc., 赛默飞世尔科技公司.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 全面覆盖不同细分市场, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the USA Rapid Pathogen Detection Market
– Identify segments/areas to invest in over the forecast period in the USA Rapid Pathogen Detection Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.